CD26 (dipeptidyl aminopeptidase IV) expression in normal and diseased human thyroid glands

Endocrine Pathology

Volumn 9, Issue 1, 1998, Pages 43-52

  Lima, Marcus A ^a,c   Gontijo, Valéria A ^a   Schmitt, Fernando C L ^b  

^a Triangulo Mineiro Medical School   (Brazil)

^b UNIVERSITY OF PORTO   (Portugal)

^c FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

CD26; Cell proliferation; Dipeptidyl aminopeptidase IV; Immunohistochemistry; Thyroglobulin; Thyroid

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ARTICLE; CANCER DIAGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THYROID DISEASE;

EID: 0031799072     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739951     Document Type: Article

References (38)

1. McDonald JK, Shwabe C. In: Barreta AJ, ed. Proteinases in mammalian cells and tissues. Amsterdam: North Holland, 1977; 371-376.
2. Kenny AJ, Maroux S. Topology of microvillar membrane hydrolases of kidney and intestine. Physiol Rev 62:91-128, 1982.
3. Semenza G. Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubule. Ann Rev Cell Biol 2:255-313, 1986.
4. Feller AC, Radzun HJ, Heymann E, Haas H, Schoez W, Parwaresch MR. A monoclonal antibody detecting dipeptidylpeptidase IV in human tissue. Virchows Arch [Pathol Anat] 409:263-273, 1986.
5. Hartel S, Gossraw R, Hanski C, Reutter W. Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry. Histochemistry 89:151-161, 1988.
6. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapinc, Trotot P, et al. Dipeptidyl peptidase IV (CD26) gene expression in enterocyte like colon cancer cell line HT-29 and Caco2. J Biol Chem 267:4824-4833, 1992.
7. Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C. Cloning and functional expression of the T-cell activation antigen CD26. J Immunol 149:481-486, 1992.
8. Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SP, Morimoto C. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J Immunol 147:2825-2832, 1991.
9. Fox DA, Hussey RE, Fitzgerald KA, Acuto O, Poole G, Palley E, Daley JF, Schlossman SF, Reinherz EIT. A novel 105-kD human T cell activation antigen defined by a monoclonal antibody. J Immunol 133:1250-1256, 1984.
10. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 48:1936-1942, 1988.
11. Rousset M, Trugnan G, Brun JL, Zweibaum A. Inhibition of the post-translational processing of microvillar hydrolases is associated with a specific decreased expression of sucraseisomaltase and an increased turnover of glucose in Caco-2 cells treated with monensin. FEBS Lett 208:34-38, 1986.
12. Trugnan G, Rousset M, Chantret I, Barbat A, Zweibaum A. The post-translational processing of sucrase-isomaltase in HT-29 cells is a function of their state of enterocytic differentiation. J Cell Biol 104:1199-1205, 1987.
13. Gossrau R. Peptidases II. Localization of dipeptidylpeptidase IV (DPP IV). Histochemistry 60:231-248, 1979.
14. Aratake Y, Kotani T, Tamura K, Araki Y, Kuribayashi T, Konoe K, Ohtaki S. Dipeptidyl aminopeptidase IV staining of cytological preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol 96:306-310, 1991.
15. Kotani T, Aratake Y, Ogata Y, Umeki K, Araki Y, Hirai K, Kuma K, Ohtaki S. Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma. Cancer Lett 57:203-208, 1991.
16. Kotani T, Asada Y, Aratake Y, Umeki K, Yamamoto I, Tokudome R, Hirai K, Kuma K, Konoe K, Araki Y, Ohtati S. Diagnosis usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours. J Pathol 168:41-45, 1992a.
17. Tanaka T, Umeki K, Yamamoto I, Sakamoro F, Noguchi S, Ohtaki S. CD26 (Dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int J Cancer (Pred Oncol) 64:326-331, 1995.
18. Rose DSC, Maddox H, Brown DC. Which proliferation markers for routine immunohistology? A comparison of five antibodies. J Clin Pathol 47:1010-1014, 1994.
19. Schmitt FC, Ferreira, MP. MIB-1 is a suitable marker of proliferative activity in formalin fixed, paraffin-embedded sections of breast cancer. Int J Surg Pathol 2:287-294, 1995.
20. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489-503, 1990.
21. Hall A, Woods AL. Immunohistochemical markers of cellular proliferation: achievements problems and prospects. Cell Tissue Kinet 23:505-5(22), 1990.
22. LiVolsi VA. The thyroid and parathyroid. In: Sternberg SS, ed. Diagnostic surgical pathology. New York: Raven, 1994; 523-560.
23. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. WHO international histological classification of tumours, 2 ed. Berlin: Springer-Verlag, 1988.
24. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911, 1989.
25. Rosai J, Carcangiu ML, DeLellis RA. The normal thyroid gland. In: Rosai J, Carcangiu ML, DeLellis RA, eds. Atlas of tumor pathology. Tumours of the thyroid gland. Washington: Armed Forces Institute of Pathology, 1992; 1-343.
26. Blumenthal HT, Perlstein IB. The aging thyroid. I. A description of lesions and an analysis of their age and sex distribution. J Am Geriatr Soc 35:843-854, 1987.
27. Lima MA, Schmitt FCL. Expression of dipeptidyl aminopeptidase IV (CD26) in human thyroid tissues. Acta Cytologica (in press).
28. Kotani T, Kawano JI, Suganuma T, Hirai K, Umeki K, Aratake Y, Konoe K, Ohtaki S. Immunohistochemical localization of dipeptidyl aminopeptidase IV in thyroid papillary carcinoma. Int J Ex Pathol 73:215-222, 1992b.
29. Bednarczyk JL, Carroll SM, Marin C, McIntyre BW. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J Cell Biochem 46:206-218, 1991.
30. Fleisher B. A novel pathway of human T-cell activation via a 103-kD T-cell activation antigen. J Immunol 138:1346-1350, 1987.
31. Tanaka T, Kameoka J, Yaron A, Schlossman SF, Morimoto C. The cosrimulatory activity of the CD26 antigen requires dipepridyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90:4586-4590, 1993.
32. Umeki K, Tanaka T, Yamamoto I, Aratake Y, Kotani T, Sakamoto F, et al. Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues. Endocrine Journal 43:53-60, 1996.
33. Fagin JÁ. Genetic basis of endocrine disease 3. Molecular defects in thyroid gland neoplasia. J Clin Endocrinol Metabol 75:1398-1400, 1992.
34. Bibbo M, Bartels H, Galera-Davidson H, Dytch HE, Wied GL. Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors. Anal Quant Cytol Histol 8:168-176, 1986.
35. Galera-Davidson H, Valverde-Villarejo B, Fernández-Rodríguez A. Signos cariométricos subvisuales en el carcinoma folicular del tiroides. Patología 25:301-306, 1992.
36. Reid WA, Valler MJ, Kay J. Immunolocalization of cathepsin D in normal and neoplastic human tissues. J Clin Pathol 39:1323-1330, 1986.
37. Métayé T, Millet C, Kraimps IL, Aubouin B, Barbier J, Bégon F. Estrogen receptors and cathepsin D in human thyroid tissue. Cancer 72:1991-1996, 1993.
38. Kraimps JL. Cathepsin D in normal and neoplastic thyroid lesions. Surgery 118:1036-1040, 1995.